Antibiotic Stewardship: Our commitment to healthier animals

Antimicrobial resistance is a critical, complex issue. At Elanco, we have been working for many years with leaders across human and animal health to develop long-term, responsible solutions. To reduce the need for antibiotics to treat animal illness, Elanco is increasingly focused on disease prevention and early disease detection, and we’re excited about the progress made to date in this space.


Our progress

As a company dedicated to the health and welfare of animals, Elanco instituted a multi-faceted 8-point plan in 2014 to help increase responsible antibiotic stewardship, reduce the need for antibiotics and replace them with alternatives. These efforts were designed to help protect the long-term viability of antibiotics, while also providing veterinarians, farmers and pet owners with the tools they need to keep animals, and people, healthy.

Given my training in human infectious disease and my last 21 years in animal health, I understand first-hand the important role antibiotic stewardship plays in both human and animal health. Stewardship requires both greater clarity around responsible use of antibiotics and focus on finding new solutions and alternatives to solve our most pressing healthcare concerns around antibiotic resistance.

Dr. S. Simjee, Chief Medical Officer

More Tools in the Toolbox

Antibiotics are critical in supporting the health and well-being of farm animals and pets. But antibiotics are only one of the tools needed to maintain animal health and welfare. By understanding and partnering with veterinarians and farmers, we can target the use of antibiotics and reduce the risk of antibiotic resistance development.

It is all our responsibility to continue to find new and better ways to keep animals healthy, produce safe food and practice good antibiotic stewardship. Along with consistent, thorough application of best practices, the responsible use of antibiotics will help ensure the health of animals and improve food safety for the next generation and beyond.

Commitment to continued improvement

Seven years after issuing our initial plan, our commitment continues to be on increasing focus on best practices and disease prevention to reduce the need for medically important antibiotics (those used in both humans and animals). This vision is not just moving from treatment to prevention, but proactively developing awareness and technologies that promote health even before an animal’s life begins.

Elanco is committed to:

  • Food chain stakeholder engagement: Help stakeholders across the food chain better understand and implement responsible antibiotic use guidelines
  • Global antibiotic classification: Consider the role of WHO, OIE, National and Regional ranking recommendations
  • Disease treatment: Support the administration of an antibiotic to an individual or a group of animals showing clinical signs of an infectious disease
  • Disease control: Support the administration of antibiotics for disease metaphylaxis/control in animals identified by a veterinarian
  • Disease prevention: Support the administration of antibiotics for disease prevention/prophylaxis where determined by a veterinarian that animals are likely to get sick
  • Utilization of risk assessment: Following a risk assessment process, where regulations allow, support the use of non-medically important antimicrobials for performance indications
  • Recording of antibiotic therapy: Antibiotic usage in farm animals should be recorded and kept by the veterinarian and/or farmer
  • Concomitant use: Two medically important antibiotics of different classes should not be used concomitantly for the same disease indication (unless approved by the regulatory agency, or supported by scientific evidence and/or veterinarian experience)
  • Aquaculture: Antibiotics in aquaculture is supported where environmental exposure of the antibiotics can be sufficiently controlled to avoid environment impact or risk of resistance development

With these commitments, Elanco continues to build on international guidelines laid out by the World Organization for Animal Health (OIE) and Codex Alimentarius. Elanco is confident these principles can meaningfully limit the risk from antibiotic resistance and protect sustainable animal production and pet health well into the future.

다른 내용이 궁금하십니까?

엘랑코와 동물건강에 관한 자사의 관점을 아래의 기사로 알아보세요.

제품 & 서비스

더 건강한 경제 동물과 반려동물을 위한 엘랑코의 제품과 서비스를 통해 당사의 혁신적인 솔루션을 알아보세요.

프로그램 & 이니셔티브

고객과 공유하는 Food and Companionship Enriching Life에 대한 우리의 비전에 대해 자세히 알아보세요.

연구 & 개발

산업 전문지식과 데이터 중심의 인사이트로 엘랑코가 동물 건강 혁신에 관해 고민하고 해결하는 법을 알아보세요.


About Elanco

About Elanco

엘랑코가 동물의 건강을 지키고 증진하는 혁신적인 해결책을 가진 일류 동물약품 기업인 이유를 알아보세요.

엘랑코 더 알아보기

Connect with Elanco

나라 선택

Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2021 Elanco.
EM-GLB-CA-20-0041